19 September 2014; Hanh Phuc – Hanh Phuc International Hospital,(HANH PHUC) the 1st Singapore Standard Hospital in Vietnam is proud to announce its collaborative partnership with Genea – a World Leading Fertility in Sydney, Australia through its appointed Joint Venture partner in Thailand Superior A.R.T. – a hi-tech assisted reproduction and genetics company in Bangkok, Thailand.

HANH PHUC has evolved itself from being just an International Women’s & Children’s Hospital to become an International Hospital devoted to healthcare for the family. The Fertility Centre in HANH PHUC was opened in October 2011. The state-of-the art facility resolves to adopt the best practices of assisted reproduction techniques in order to bring to Vietnam the very best of fertility treatments. In July 2014, HANH PHUC’s Fertility Centre achieved the RTAC Accreditation, thus endorsing itself as a Fertility Centre adopting and practicing International standards of reproduction techniques.

“Since the opening of Hanh Phuc’s business in Vietnam market in 2011, it has striven to bring all the medical quintessence from the world to Vietnam and to provide a high standard of clinical quality care to serve our patients in Vietnam.

Our Fertility Centre is no exception. The Centre is continually striving to bring the very best in assisted reproductive standards and technologies to Vietnam. The Centre sets high standards for observing patient safety and laboratory techniques. It has consistently achieved high success in pregnancy rates and has helped many couples in Vietnam fulfill their dreams of having a baby.

In July this year, the Fertility Centre was awarded the RTAC Accreditation, an international recognition and endorsement of the high standards it maintains for the patients and their procedures. Not one to rest on its laurels, the Fertility Centre continues to seek to improve and benchmark itself against other reputable international Fertility facilities.

Today, it gives me great pleasure to announce our collaborative partnership with Genea Australia, through their appointed Regional Joint Venture partner Superior A.R.T., Thailand. This partnership with Genea and Superior A.R.T. is the culmination of our efforts to fulfil the promise we make to our patients – to bring the region’s if not the world’s best to Vietnam.

The partnership is another milestone in HANH PHUC’s history- to offer to couples who have difficult in conceiving; in Vietnam and its neighbouring countries the hope of becoming parents through advance Science and Technology”, Chief Executive Officer of Hanh Phuc, Mrs. Thuc Anh Nguyen said.

Mr. Sarayuth Assamakorn, Managing Director at Superior A.R.T said, “We are very excited about this partnership! Superior A.R.T., a leading IVF and reproductive genetic provider in Thailand and Asia, has outstanding assisted reproductive techniques and know-how as a result of our affiliation with Genea and their vigorous standards in protocols, procedures and training, as well as their cutting-edge research and development. This venture projects our vision of Superior A.R.T. and its collaborative partners, such as Hanh Phuc, being a fertility hub in Asia, helping more people have healthy babies and complete their families”.

For more than 25 years, Genea has built a reputation as a pioneer of fertility treatment. Their research and technology development sets them as world leaders in assisted reproductive techniques and technology. Mr. Steven McArthur, Scientific Director at Genea, said “Genea takes 25 years of clinical insights at Genea Fertility and combines them with almost 25 years of investment in research and development to create and commercialize IVF laboratory technology for the global fertility market. This provides patients with success rates that are amongst the best in the world and will continue to improve”.

“In addition, Genea Biocells has developed the world’s largest and most varied private bank of human embryonic stem cells, with cell lines representing almost 30 genetic diseases, enabling advances in research and drug discovery in areas of unmet medical need,” Mr. McArthur said.

It is the aim of this exciting collaboration between Genea through its joint venture partner Superior A.R.T. and Hanh Phuc International Hospital to allow their success to be extended to the Fertility Centre of HANH PHUC, to the benefit of patients in Vietnam and the surrounding region, significantly improving their chances of a healthier pregnancy and a healthy child.

About Hanh Phuc International Hospital:

Hanh Phuc International Hospital (HANH PHUC) is the first Singapore standard hospital in Vietnam. Opened in January 2011, HANH PHUC started as a Women’s & Children’s Hospital and in a short span of 3 years has successfully been granted a Multi-Specialty hospital status.

HANH PHUC operates a tertiary care private hospital located on the fringe of Ho Chi Minh City in the Binh Duong Province. Despite its Multi-Specialty hospital status, the 258-bed hospital continues to focus and expands its services for Obstetrics, Gynaecology and Paediatrics, with Specialist clinics for Women Cancer, Fertility and Cosmetic Surgery.

In 2013, our (493 square meters) clinic in Ho Chi Minh City moved to a new premise occupying all 9 floors of a building in the heart of Ho Chi Minh City providing both care and convenience to our patients.

HANH PHUC is continually raising the bar on clinical excellence; we believe in bringing the best medical and healthcare services from the world to the people of Vietnam. We are sensitive to our patients’ needs for a world class hospital experience and are dedicated to provide a family-oriented and personalized care to our patients.

About Genea

In the 1980s, Genea, then known as Sydney IVF were the IVF pioneers in Australia. Over the years, our scientists and clinicians have been at the forefront of world leading breakthroughs in fertility technologies as well as treatments.

These days, we provide services across states and countries well beyond Sydney and we do so much more than IVF – we lead the way in fertility technology and services.

As Genea, we maintain our proud tradition of investing in research and development, a commitment that means our fertility clinics are able to offer truly world leading science. No other clinic in Australia invests as much as Genea in fertility R&D.

And constantly striving to improve our technology and techniques has made a real difference to Genea patients – leading to a birth rate more than 40 per cent higher than the average of other clinics in Australia and New Zealand.

These days, we provide services across states and countries well beyond Sydney and we do so much more than IVF – we lead the way in fertility technology and services.

As Genea, we maintain our proud tradition of investing in research and development, a commitment that means our fertility clinics are able to offer truly world leading science. No other clinic in Australia invests as much as Genea in fertility R&D.

And constantly striving to improve our technology and techniques has made a real difference to Genea patients – leading to a birth rate more than 40 per cent higher than the average of other clinics in Australia and New Zealand.

 takes the clinical insights discovered by Genea Fertility and combines them with almost 25 years of investment in research and development to create and commercialise IVF laboratory technology to the global fertility market. Genea Biomedx is assisted by Genea Fertility to undertake rapid clinical verification and evaluation of these new technologies and in turn, these new technologies create improved chances for patients of Genea Fertility.

Under licensed embryo research projects,  has developed the world’s largest and most varied private bank of human embryonic stem cells, with cell lines representing almost 30 genetic diseases. These cell lines are available for use to advance research and drug discovery in areas of unmet medical need, including in relation to the very genetic diseases that directly affect the families of Genea’s PGD patients.

About Superior A.R.T.:

Superior A.R.T was founded to enable this groundbreaking assisted reproduction treatment and technology to be accessible to and benefit patients in the greater Eastern and South-East Asia region.

It has achieved world class pregnancy rates for both IVF and genetic patients. Superior A.R.T.’s highly successful PGD HLA matching program led to the selection of Asia’s first PGD selected thalassemia free and sibling HLA matched embryo, with birth, cord blood stem cell collection and curative bone marrow transplantation in a thalassemia affected sibling.